pharmaphorum2d
Algiax non-opioid drug works in chronic neuropathic pain
The encouraging result comes just days after the US FDA approved Vertex Pharma's non-opioid painkiller Journavx (suzetrigine) ...
Promising Outlook for Lexicon Pharmaceuticals’ LX9211 as a Novel Treatment for Diabetic Peripheral Neuropathic Pain
Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on LXRX stock, giving a Buy rating yesterday.Invest with Confidence: ...
What Really Works for Nerve Pain
Have you experienced pain or tingling in your hands or feet? Those are signs of possible neuropathy, “a general term for ...
GlobalData on MSN7d
FDA approves Vertex’s acute pain treatment Journavx
The FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.
Healthline7d
CBD for Nerve Pain: 5 Products to Try in 2025
Certain conditions, such as diabetes, may increase your risk of neuropathy, which could lead to neuropathic pain. CBD lotions, creams, and salves may help reduce aches and pains. It’s unclear ...
BioPharma Dive6d
A new, non-opioid pain drug is here. Getting it to patients could be agony.
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
BioSpace2d
Algiax’s Non-Opioid Drug Reduces Neuropathic Pain in Mid-Stage Trial
The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...